VSTM
NASDAQ · Biotechnology
Verastem Inc
$8.54
+0.55 (+6.88%)
Open$8.03
Previous Close$7.99
Day High$8.66
Day Low$8.00
52W High$10.82
52W Low$3.43
Volume—
Avg Volume2.38M
Market Cap662.92M
P/E Ratio—
EPS$-2.46
SectorBiotechnology
Analyst Ratings
Strong Buy
15 analysts
Price Target
+64.5% upside
Current
$8.54
$8.54
Target
$14.05
$14.05
$11.84
$14.05 avg
$17.49
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 38.00M | 14.27M | 326.86M |
| Net Income | -257,526,531 | -167,775,411 | 9.66M |
| Profit Margin | -677.6% | -1,241.1% | 3.0% |
| EBITDA | -211,403,012 | -176,249,033 | 19.14M |
| Free Cash Flow | — | — | 10.52M |
| Rev Growth | +128.2% | +69.6% | +8.0% |
| Debt/Equity | 1.51 | 0.51 | 0.80 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $265.21 | +0.28% | 74.0 | 466.74B |
| AMGN | Amgen Inc | $410.24 | +4.34% | 23.7 | 207.25B |
| GILD | Gilead Sciences Inc | $152.67 | +1.40% | — | 187.10B |
| VRTX | Vertex Pharmaceuticals Inc | $514.99 | +0.84% | 29.7 | 130.64B |
| REGN | Regeneron Pharmaceuticals | $803.90 | +0.72% | 18.6 | 80.58B |
| ALNY | Alnylam Pharmaceuticals Inc | $251.65 | +3.00% | 40.0 | 32.33B |